Day 1

 

Day 2
Day 3
Resources

Please find the session links next to their corresponding agenda item.

Tuesday, April 20

12:00 PM 

FDLI Welcome and Announcements
Khara L. Minter, Assistant Director, Training Programs, FDLI

Enter this session: https://fdli.zoom.us/j/99846820354

12:05 – 1:10 PM 

Overview of Drug Law and Regulation
Joseph E. McGuinness
, Independent Consultant, EAS Consulting Group

Enter this session: https://fdli.zoom.us/j/99846820354

1:10 – 1:20 PM 

Break

1:20 – 2:35 PM 

The New Drug Approval Process: Basic Concepts
Bert Lao, Senior Associate, Hogan Lovells US LLP

Enter this session: https://fdli.zoom.us/j/97532615239

2:35–2:45 PM

Break

2:45 – 4:00 PM

The New Drug Approval Process: New Drug Research and Development
Marian J. Lee, Partner, Gibson Dunn & Crutcher LLP

Enter this session: https://fdli.zoom.us/j/97052147067

4:00–4:15 PM

Break

4:15–5:00 PM

FDA’s COVID-19 Activities
Jacqueline R. Berman, Partner, Morgan, Lewis & Bockius LLP

Enter this session: https://fdli.zoom.us/j/95128611713

FAQ

This course is pending CLE approval in Virginia and Ohio. During the course, there will be periodic polling to ensure you are still listening. This will let us know if you completed the necessary hours to receive CLE credit. Please email [email protected] at the end of the conference to obtain forms.

Please find the session links next to their corresponding agenda item.

We will be using Zoom Webinars to conduct this Introductory course. If you have any technical issues throughout the course, please visit the Zoom Help Center here: https://support.zoom.us/hc/en-us/articles/206175806

Yes. Please contact Coleen Carney at [email protected] if you require dial-in numbers.